Japanese firm Ono Pharmaceuticals and US company BioSeek have entered into a drug discovery agreement based on bioactive lipids.

Under the agreement, Ono will pay research funds and milestone payments to BioSeek and the latter will be responsible for lead identification using its proprietary discovery technologies.

Ono will then have worldwide rights to develop and sell any pharmaceutical product containing a compound developed through this collaboration.